HopeStage
Back to overview

ADHD studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 217-228 of 1,811
Behavioral study icon
CompletedNCT01098058

Cognitive-Behavioural Therapy (CBT) for Adult Attention Deficit Hyperactivity Disorder (ADHD)

Official study title

A Proof of Concept Randomised Controlled Trial to Examine the Potential Efficacy, Patient Acceptability and Feasibility of Cognitive-behavioural Therapy for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

This study has finished and is no longer accepting participants.

In London
ADHDInterventional studyAges 18–65
Countries
United Kingdom
Sponsor
South London and Maudsley NHS Foundation Trust
Behavioral study icon
CompletedNCT02716324

Communication to Improve Shared Decision-Making in ADHD

Official study title

Communication to Improve Shared Decision-Making in Attention-Deficit/Hyperactivity Disorder

This study has finished and is no longer accepting participants.

In Philadelphia
ADHDBehavioural studyAges 5–12
Countries
United States
Sponsor
Children's Hospital of Philadelphia
Drug study icon
CompletedNCT01106430

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

Official study title

A Phase 3b, Double-blind, Randomised, Active-controlled, Parallel Group Study to Assess the Time to Response of Lisdexamfetamine Dimesylate to Atomoxetine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) Who Have Had an Inadequate Response to Methylphenidate Therapy

This study has finished and is no longer accepting participants.

Multiple locations, including Dothan
ADHDMedication studyAges 6–17
Countries
United States, Canada, United Kingdom, + 7 others
Sponsor
Shire
Drug study icon
CompletedNCT03904498

COMT Inhibition Among Individuals With Comorbid AUD/ADHD

Official study title

COMT Inhibition as a Potential Therapeutic Target Among Individuals With Comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder

This study has finished and is no longer accepting participants.

In Aurora
ADHD, AddictionMedication studyAges 21–65
Countries
United States
Sponsor
University of Colorado, Denver
Drug study icon
CompletedNCT02276209

Dasotraline Adult ADHD Study

What is this study about?

Researchers compared Dasotraline and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Phoenix
ADHDMedication studyAges 18–55
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Drug study icon
CompletedNCT02428088

Dasotraline Pediatric ADHD Study

What is this study about?

Researchers compared Dasotraline and placebo to find out how the approaches affected ADHD symptoms in people with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Dothan
ADHDMedication studyAges 6–12
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.